J 2011

The atherogenic index of plasma is increased by hormonal contraception

SOŠKA, Vladimír, Jindřich FIALA, Kateřina NEBESKÁ, Jiří JARKOVSKÝ, Drahoslava HRUBÁ et. al.

Basic information

Original name

The atherogenic index of plasma is increased by hormonal contraception

Authors

SOŠKA, Vladimír (203 Czech Republic, guarantor, belonging to the institution), Jindřich FIALA (203 Czech Republic, belonging to the institution), Kateřina NEBESKÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Drahoslava HRUBÁ (203 Czech Republic, belonging to the institution)

Edition

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, NORWAY, TAYLOR & FRANCIS AS, 2011, 0036-5513

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.156

RIV identification code

RIV/00216224:14110/11:00056966

Organization unit

Faculty of Medicine

UT WoS

000288126400004

Keywords in English

Oral contraceptives; dyslipidemias; cardiovascular diseases; risk factors; HDL cholesterol; triglycerides; C-reactive protein

Tags

International impact
Změněno: 12/4/2012 09:40, Mgr. Michal Petr

Abstract

V originále

The aim of this study was to determine if hormonal contraceptives affect the new atherogenic index of plasma (AIP) = log[triglycerides (TG)/high-density lipoprotein cholesterol (HDL-C)] together with the total cholesterol/HDL-C (TC/HDL-C) and the apolipoprotein B/apolipoprotein A1 (apoB/apoA1) ratios. The increased AIP and hs-CRP concentration after 9 months of hormonal contraception demonstrate that contraceptive-induced dyslipidemia has a proatherogenic nature, even when the TC/HDL-C and the apoB/apoA1 ratios are unchanged.

Links

NR8841, research and development project
Name: Hodnocení účinků různých typů hormonálních kontraceptiv na biochemické ukazatele kardiovaskulárního rizika žen s rozdílným kuřáckým a výživovým chováním a možnosti jejich ovlivnění
Investor: Ministry of Health of the CR